Goldman Sachs Exchanges cover image

Weighing the GLP-1 Market

Goldman Sachs Exchanges

00:00

Medicare Coverage Discrepancy for GLP-1 Medications

Exploring the disparities in insurance coverage for GLP-1 medications for obesity treatment, particularly focusing on the lack of Medicare coverage compared to diabetes medications. The chapter analyzes the potential costs and implications of expanding Medicare coverage for these drugs in the US.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app